To comply with EU FMD Fareva selects TraceLink

Published: 8-Oct-2018

The API CDMO has selected the track and trace network provider, so that it can successfully connect with its pharmaceutical customers

Fareva has selected a serialisation solution from TraceLink to ensure compliance with the EU Falsified Medicines Directive (FMD).

Fareva is a global pharmaceutical and API contract development and manufacturing organisation producing various dosage forms, APIs and packing options. TraceLink is a track and trace network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes.

TraceLink and Fareva will be at CPhI Worldwide, stand 3C30, partnering to provide education around EU FMD readiness and serialisation.

With more than 1000 customers, Fareva operates 35 sites across Europe, Russia, Turkey and The Americas. As a leading global CDMO, Fareva needed a serialisation solution that could not only ensure compliance ahead of the February 2019 deadline, but one that enabled successful data exchange.

TraceLink was selected because of its network-tenant platform and its proven ability to facilitate fast and comprehensive integration to CDMOs, allowing Fareva to connect with its pharmaceutical customers.

“Serialization impacts every aspect of the pharmaceutical supply chain, and as a CDMO, we recognize the critical role we play in regard to industry preparedness,” said Sebastien Poncet, Vice-President of Sales at Fareva.

“After a thorough evaluation, TraceLink stood out as the only provider who had a solution that would eliminate the time-intensive and cost prohibitive task of point-to-point connections, while also allowing us to streamline data exchange with our customers and support them in being compliant with serialization regulations. More than 500 CMOs are fully-configured on the TraceLink Life Sciences Cloud and ready to exchange serialisation data," said Poncet.

You may also like